131.75 0.06 (0.05%)

New 52W High today

1.9M XNAS Volume

XNAS 27 Mar, 2025 5:30 PM (EDT)

Intra-Cellular Therapies Inc - ITCI - stock price prediction, stock price target, analyst ratings from 12 analysts

Intra-Cellular Therapies Inc has a share price target of US$ 132, revenue growth forecast of 39.6%, and profit growth estimate of 147.3% for FY25, based on top 12 analyst calls.